Arthneeti

Aster DM Healthcare Q1 FY27 Share Price & Earnings Call Analysis

₹681.15+0.29% today
Market cap
₹59,405 Cr
P/E
164.59
ROE
11.28%
PEG
-134.91
Price to sales
12.18
Debt to equity
0.62
52W high / low
₹870 / ₹538
Sales growth (5Y)
-11.61%
EBITDA margin
18.83%
Net profit margin
9.70%
Promoter holding
53.72%
Sales (last year)
₹4,876 Cr

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Guidance scorecard · Q1 FY27 call

What Aster DM Quality Care Ltd's management guided
and where it ranks in Healthcare Services

#3of 33 in
Healthcare Services
Revenue20–40%MarginsUp 2%+CapexPlannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

20–40%
  • Revenue growth driven by higher patient volumes and increased realizations due to complex case mix.
  • Over 2 million patients treated in Q1, up 13% YoY; blended occupancy increased by 510 bps to 64%.
  • Mature Units (73% revenue) grew 19% YoY; Focus Units (15% revenue) grew 16% YoY; Emerging Units grew 63% YoY.
  • Emerging hospitals like Kasaragod achieved fast ramp-up, reaching EBITDA breakeven in 9 months.
  • Organic growth target: 5%-6% volume growth and 7%-8% ARPP growth.
  • Medical Value Travel (MVT) revenue growing 62% YoY; management aims to grow MVT faster than overall business, targeting mid to double-digit share in revenue.

2 more points from Aster DM Quality Care Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Up 2%+

See what Aster DM Quality Care Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Bhubaneswar project is on the radar for expansion.
  • New cancer center inauguration planned in Raipur by mid-August 2026.
  • Capacity additions planned in 2028 at Kottayam and Nagercoil (bed additions ongoing).
  • Bed additions also happening at Banjara Hills, Nampally, and Shifa by 2028.
  • Greenfield projects include Trivandrum hospital expected operational by H2 FY27 (~January 2027).
  • Hyderabad hospital in interior work phase; planned operationalization by April 2027 (FY28 start).
  • Sarjapur project (~450 beds, two blocks) work already started on Block 1 focused on MEP and interiors.

2 more points from Aster DM Quality Care Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Aster DM Quality Care Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Ask what Aster DM Quality Care Ltd said on the order book →

Full Q1 FY27 analysis
Full Healthcare Services ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. This stockAster DM Quality Care LtdGood growth
    3
See all potential multibaggersAll Healthcare Services rankings

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹903 Cr—
240%+Flat₹583 Cr22.2
3Aster DM Quality Care LtdThis stock20–40%Up 2%+₹58,782 Cr162.9
420–40%Up 0–2%₹1,730 Cr17.5
520–40%Up 0–2%₹580 Cr11.9
620–40%Flat₹1.13L Cr53.9

Sign up free to see every company in the sector ranking and track Aster DM Quality Care Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of Aster DM Quality Care Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Aster DM Quality Care Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +8078419299559741,0021,0861,0501,0001,0781,1971,1861,182
Expenses +687722787805817841869864818876961983958
Operating Profit120119142149156161217186182202236202224
OPM %15%14%15%16%16%16%20%18%18%19%20%17%19%
Other Income +149-17-64153-405,12035952928-037
Interest25253025302931313231313130
Depreciation54515457586062626463666867
Profit before tax19026-7220285,19115910291136167103163
Tax %4%24%120%5%108%1%33%37%6%31%27%43%6%
Net Profit +18320-15209-25,15210664869412159154
EPS in Rs3.420.10-0.623.59-0.48103.001.941.141.581.652.121.012.71

Financials of Aster DM Quality Care Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +3,8765,2505,9316,7217,9638,6528,60810,2532,9943,6994,1384,643
Expenses +3,3704,8055,5826,0896,8867,1877,5068,7202,5473,1243,3843,779
Operating Profit5064453496321,0771,4651,1031,533447575754864
OPM %13%8%6%9%14%17%13%15%15%16%18%19%
Other Income +2325453177-155-1585351353325,16993
Interest7918937120420539133430796119133123
Depreciation144243322298306586618641192220249264
Profit before tax306381083084103302056375112685,542570
Tax %11%78%10%8%10%5%13%6%7%21%2%25%
Net Profit +2728982823673151786014752125,408427
EPS in Rs7.000.202.525.326.595.542.9610.538.512.59107.667.49
Dividend Payout %0%0%0%0%0%0%0%0%0%4,637%5%40%

Financials of Aster DM Quality Care Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital389403403505505497497500500500500518
Reserves1,096171,4722,3272,7092,7752,8753,0803,5743,6862,5544,058
Borrowings +1,0913,3212,7582,3522,7885,6054,8045,2826,0751,7582,3922,220
Other Liabilities +1,8342,0032,1712,2962,9263,5283,4443,6614,68712,0391,1541,316
Total Liabilities4,4095,7436,8047,4798,92812,40511,62012,52114,83617,9836,6008,112
Fixed Assets +2,2372,5073,5203,7384,2897,1246,7497,0099,0523,1753,9204,249
CWIP197358290402550736934998279170293413
Investments33932382234634580172451,167
Other Assets +1,9722,8392,9623,3024,0674,5113,8744,4705,42514,6202,1422,284
Total Assets4,4095,7436,8047,4798,92812,40511,62012,52114,83617,9836,6008,112

Financials of Aster DM Quality Care Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +2362033615376011,2231,5691,3141,834158425656
Cash from Investing Activity +-439-775-1,136-522-702-658-333-563-951-8786,015-288
Cash from Financing Activity +20357865446134-675-1,116-686-8171,053-6,358-304
Net Cash Flow-15-1226133-11012065663328263
Free Cash Flow-176-536-56523647151,183770995-60170179
CFO/OP51%53%116%93%61%88%143%89%424%40%72%94%

Financials of Aster DM Quality Care Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days83937984931008672285232324
Inventory Days9392102111110138122129612443632
Days Payable1781871511501533032902671,400183166168
Cash Conversion Cycle-2-1304550-65-83-66-503-116-107-112
Working Capital Days696865928855-21272-32-28
ROCE %14%6%1%7%13%12%6%10%3%4%11%11%

Guidance history

How Aster DM Quality Care Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%Up 2%+Planned——
Q4 FY26 call →10–20%FlatPlanned——
Q4 FY26 call →10–20%FlatPlanned——
Q3 FY26 call →10–20%Up 2%+Planned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

25out of 100

Momentum score · price trend

25 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−2.4%59%
Last 6 months−2.8%51%
Last 3 months−17.2%27%

The price is 21.7% below its all-time high of ₹869.7 (7 Aug 2026). Stocks more than 20% below their peak have their score halved, so 50 became 25.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Aster DM Quality Care Ltd: 0.4 × 59 + 0.4 × 51 + 0.2 × 27 = 50, halved to 25 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Aster DM Quality Care Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Max Healthcare Institute Ltd (Q2 FY27)

    Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

  • Indegene Ltd (Q2 FY27)

    Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo

Compare:vs Apollo Hospitals Enterprise Ltdvs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltd